The role of genetic factors in the occurrence of levodopa-induced motor complications in Parkinson's disease

被引：0
|
作者：
Radojevic, B.
Dragasevic-Miskovic, N.
Milovanovic, A.
Petrovic, I.
Svetel, M.
Jancic, I.
Stanisavljevic, D.
Milicevic, O.
Savic, M.
Kostic, V.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
CATECHOL-O-METHYLTRANSFERASE; RISK; POLYMORPHISMS; ASSOCIATION; DYSKINESIAS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1106
引用
收藏
页码：S487 / S487
页数：1
相关论文
共 50 条
  • [21] The role of genetic factors in levodopa-induced dyskinesias development in Russian patients with Parkinson's disease: A pilot study
    Akhmadeeva, G.
    Khidiyatova, I.
    Gilyazova, I.
    Baitimerov, A.
    Magzhanov, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [22] A meta-analysis of the effectiveness and safety of safinamide for levodopa-induced motor complications in Parkinson's disease
    Li, Jiaojiao
    Zhang, Jianyu
    Meng, Pin
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (04) : 4627 - 4638
  • [23] Putaminal dopamine turnover in de novo Parkinson's disease predicts levodopa-induced motor complications
    Loehle, M.
    Mende, J.
    Wolz, M.
    Beuthien-Baumann, B.
    Oehme, L.
    van den Hoff, J.
    Kotzerke, J.
    Reichmann, H.
    Storch, A.
    MOVEMENT DISORDERS, 2015, 30 : S13 - S14
  • [24] Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease.
    Meloni, M.
    Puligheddu, M.
    Cannas, A.
    Figorilli, M.
    Defazio, G.
    Carta, M.
    MOVEMENT DISORDERS, 2019, 34 : S65 - S65
  • [25] Levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    Lee, J
    Venderova, K
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
  • [26] Levodopa-induced migraine in Parkinson's disease
    Gunzler, S. A.
    MOVEMENT DISORDERS, 2013, 28 : S208 - S208
  • [27] Levodopa-induced hyperhomocysteinaemia in Parkinson's disease
    Yasui, K
    Nakaso, K
    Kowa, H
    Takeshima, T
    Nakashima, K
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (01): : 66 - 67
  • [28] Levodopa-induced dyskinesia in Parkinson’s disease
    J. M. Brotchie
    J. Lee
    K. Venderova
    Journal of Neural Transmission, 2005, 112 : 359 - 391
  • [29] Risk factors for levodopa-induced dyskinesia in Parkinson's disease patients
    Djuric, Gordana
    Markovic, Vladana
    Pekmezovic, Tatjana
    Tomic, Aleksandra
    Kresojevic, Nikola
    Kostic, Vladimir
    Svetel, Marina
    VOJNOSANITETSKI PREGLED, 2017, 74 (10) : 921 - 926
  • [30] THE IMPACT OF LEVODOPA-INDUCED COMPLICATIONS ON THE QUALITY OF LIFE OF PATIENTS WITH PARKINSON'S DISEASE
    Manharlal, P. K.
    Lim, E. -C.
    Tang, E. -K.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E69 - E70
12345